Abstract:Vascular endothelial cells produce various biologically active factors regulating blood pressure, coagulation, and possibly cell growth of the vascular wall. Of the factors, nitric oxide (NO) has been the object of attention because of its quite simple molecular structure and variety of biological functions. In the present review, we focused on the physiologic and pathologic aspects of NO in hypertension. In experimental animals, both acute and chronic inhibition of NO synthase (NOS) with arginine derivatives produce a significant rise in blood pressure, indicating that tonic production of NO regulates basal vascular tonus. The chronic hypertension caused by NOS inhibitor is associated with cardiac hypertrophy and renal insufficiency. Sodium retention, though transient, and the plasma and tissue renin/angiotensin system in addition to the reduced production of NO have been implicated in the development of hypertension. Hypertension and the associated target organ failure can be reversed by co-administration of L-arginine or blockades of the renin/angiotensin system. Studies in which L-arginine as the substrate of NO or NOS inhibitor was administered demonstrated an important role of NO in the regulation of tonic vascular tonus also in normal subjects. In hypertensive subjects, however, endothelium-dependent vasorelaxation and production of NO are impaired, possibly due to a deficiency of L-arginine and/or a disorder of its utilization. Recent advances in the methods of detecting NO enabled us to demonstrate its diminished production from endothelial cells of hypertensive rats in vitro, although no definite biochemical evidence has been obtained in hypertensive subjects. The endothelial dysfunction, however, is not a primary cause of hypertension but a secondary result since it is commonly observed in various types of hypertension and can be reversed by correcting the blood pressure. Other common diseases including atherosclerosis and diabetes mellitus are also associated with similar abnormalities of the endothelium. NO has anti-atherogenic actions: inhibition of platelet functions and proliferation of vascular smooth muscle cells. Therefore, potentiation of endogenous NO and/or supplement of exogenous NO donors could be novel therapeutic approaches for the treatment of hypertension and atherosclerosis, while potential adverse effects of NO including cytotoxicity, immunosuppressibility, and hypotensive shock should be taken into account.

The Potential Role of Nitric Oxide in the Hypertrophic Growth of the Left Ventricle

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

Nitric Oxide Regulation of Myocardial O2 Consumption and HEP Metabolism.

[Clinical significance of nitric oxide in hypertension]

Aerobic Exercise Protects Against Pressure Overload-Induced Cardiac Dysfunction and Hypertrophy Via Β3-Ar-nnos-no Activation.

Endothelium-driven myocardial growth or nitric oxide at the crossroads

[Role of Mitogen-Activated Protein Kinase in the Inhibition of Myocardial Hypertrophy by Nitric Oxide in Renovascular Hypertensive Rats].

Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy

Characterization of the Role of Nitric Oxide and Its Clinical Applications

Relationship Between Hypertensive Left Ventricular Hypertrophy and Levels of Endothelin and Nitric Oxide.

Arteriogenesis: role of nitric oxide

Nitric Oxide Synthase Inhibition Abolishes Exercise-Mediated Protection Against Isoproterenol-Induced Cardiac Hypertrophy in Female Mice.

Title Vascular nitric oxide : Beyond eNOS

Myofilament Ca2 + Desensitization Mediates Positive Lusitropic Effect of Neuronal Nitric Oxide Synthase in Left Ventricular Myocytes from Murine Hypertensive Heart

[Molecular Mechanism of Nitric Oxide in Preventing Cardiomyocytes from Hypertrophic Response Induced by Angiotensin II].

Inducible NO Synthase Activity in Blood Vessels and Heart: New Insight into Cell Origin and Consequences

Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production

Effects of different nitric oxide synthases on pulmonary and systemic hemodynamics in hypoxic stress rat model

Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease

Nitric oxide modulates the frog heart ventricle morphodynamics

The potential of stimulating nitric oxide formation in the treatment of hypertension